At the European Association for the Study of Diabetes meeting, Louis J. Aronne, MD, argued that obesity medications could make bariatric surgery obsolete, thanks to drugs that treat multiple metabolic conditions. Francesco Rubino, MD, countered, suggesting “metabolic” surgery will continue to play a key role, especially for long-term management of obesity and related conditions. Aronne believes future treatments will address obesity earlier, while Rubino sees surgery remaining important for certain patients. Both agree obesity management is evolving rapidly.
Trending
- The biggest GI disruptions to prepare for in 2026 (Becker’s GI & Endoscopy)
- Colonoscopy Delay Up to 24 Months After Positive FIT Not Tied to Added CRC Risk (Medscape)
- Addressing the psychological impacts of inflammatory bowel disease (Penn Today)
- Beneath the Surface: ‘Start low, go slow’ when prescribing GLP-1 therapies (Healio)
- Preventing Ergonomic Injuries In the Endoscopy Suite (GI & Endoscopy News)
- Visual Estimation Inaccurate for Measuring Colorectal Polyps (GI & Endoscopy News)
- High Adherence to Repeat Multitarget Stool DNA Testing and Follow-Up Colonoscopy in Average-Risk United States Adults: Results from a Nationally Insured Cohort (Clinical Therapeutics)
- Is It Time To Equip Our Toilets With Health Sensors? (The Medical Futurist)
